83_FR_45422 83 FR 45249 - Request for Nominations for Voting Members on a Public Advisory Committee; Technical Electronic Product Radiation Safety Standards Committee

83 FR 45249 - Request for Nominations for Voting Members on a Public Advisory Committee; Technical Electronic Product Radiation Safety Standards Committee

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration

Federal Register Volume 83, Issue 173 (September 6, 2018)

Page Range45249-45249
FR Document2018-19355

The Food and Drug Administration (FDA) is requesting nominations for members to serve on the Technical Electronic Product Radiation Safety Standards Committee (TEPRSSC) in the Center for Devices and Radiological Health. Nominations will be accepted for current and upcoming vacancies effective with this notice. FDA seeks to include the views of women and men, members of all racial and ethnic groups, and individuals with and without disabilities on its advisory committees and, therefore, encourages nominations of appropriately qualified candidates from these groups.

Federal Register, Volume 83 Issue 173 (Thursday, September 6, 2018) 
[Federal Register Volume 83, Number 173 (Thursday, September 6, 2018)]
[Notices]
[Page 45249]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-19355]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2018-N-3233]


Request for Nominations for Voting Members on a Public Advisory 
Committee; Technical Electronic Product Radiation Safety Standards 
Committee

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is requesting 
nominations for members to serve on the Technical Electronic Product 
Radiation Safety Standards Committee (TEPRSSC) in the Center for 
Devices and Radiological Health. Nominations will be accepted for 
current and upcoming vacancies effective with this notice.
    FDA seeks to include the views of women and men, members of all 
racial and ethnic groups, and individuals with and without disabilities 
on its advisory committees and, therefore, encourages nominations of 
appropriately qualified candidates from these groups.

DATES: Nominations received on or before November 5, 2018 will be given 
first consideration for membership on TEPRSSC. Nominations received 
after November 5, 2018 will be considered for nomination to the 
committee as later vacancies occur.

ADDRESSES: All nominations for membership should be sent electronically 
by accessing FDA's Advisory Committee Membership Nomination Portal at 
https://www.accessdata.fda.gov/scripts/FACTRSPortal/FACTRS/index.cfm or 
by mail to Advisory Committee Oversight and Management Staff, Food and 
Drug Administration, 10903 New Hampshire Ave., Bldg. 32, Rm. 5103, 
Silver Spring, MD 20993-0002. Information about becoming a member on an 
FDA advisory committee can also be obtained by visiting FDA's website 
at https://www.fda.gov/AdvisoryCommittees/default.htm.

FOR FURTHER INFORMATION CONTACT: Patricio G. Garcia, Office of Device 
Evaluation, Center for Devices and Radiological Health, Food and Drug 
Administration, 10903 New Hampshire Ave., Bldg. 66, Rm. G610, Silver 
Spring, MD 20993-0002, 301-796-6875, email: 
[email protected].

SUPPLEMENTARY INFORMATION: FDA is requesting nominations for voting 
members on TEPRSSC that include three general public representatives.

I. General Description of the Committee's Duties

    The committee provides advice and consultation to the Commissioner 
of Food and Drugs (Commissioner) on the technical feasibility, 
reasonableness, and practicability of performance standards for 
electronic products to control the emission of radiation from such 
products, and may recommend electronic product radiation safety 
standards to the Commissioner for consideration.

II. Criteria for Voting Members

    The committee consists of a core of 15 voting members including the 
Chair. Members and the Chair are selected by the Commissioner or 
designee from among authorities knowledgeable in the fields of science 
or engineering, applicable to electronic product radiation safety. 
Members will be invited to serve for overlapping terms of up to 4 
years. Terms of more than 2 years are contingent upon the renewal of 
the committee by appropriate action prior to its expiration.

III. Nomination Procedures

    Any interested person may nominate one or more qualified 
individuals for membership on the committee. Self-nominations are also 
accepted. Nominations must include a current, complete 
r[eacute]sum[eacute] or curriculum vitae for each nominee, including 
current business address and/or home address, telephone number, and 
email address if available, and a signed copy of the Acknowledgement 
and Consent form available at the FDA Advisory Nomination Portal (see 
ADDRESSES). Nominations must also specify the advisory committee for 
which the nominee is recommended. Nominations must also acknowledge 
that the nominee is aware of the nomination unless self-nominated. FDA 
will ask potential candidates to provide detailed information 
concerning such matters related to financial holdings, employment, and 
research grants and/or contracts to permit evaluation of possible 
sources of conflicts of interest.
    This notice is issued under the Federal Advisory Committee Act (5 
U.S.C. app. 2) and 21 CFR part 14, relating to advisory committees.

    Dated: August 31, 2018.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2018-19355 Filed 9-5-18; 8:45 am]
 BILLING CODE 4164-01-P

Federal Register / Vol. 83, No. 173 / Thursday, September 6, 2018 / Notices 45249 part 822 have been approved under Evaluation, Center for Devices and U.S.C. app. 2) and 21 CFR part 14, OMB control number 0910–0449. Radiological Health, Food and Drug relating to advisory committees. Dated: August 30, 2018. Administration, 10903 New Hampshire Dated: August 31, 2018. Leslie Kux, Ave., Bldg. 66, Rm. G610, Silver Spring, Leslie Kux, Associate Commissioner for Policy. MD 20993–0002, 301–796–6875, email: Associate Commissioner for Policy. Patricio.Garcia@fda.hhs.gov. [FR Doc. 2018–19249 Filed 9–5–18; 8:45 am] [FR Doc. 2018–19355 Filed 9–5–18; 8:45 am] BILLING CODE 4164–01–P SUPPLEMENTARY INFORMATION: FDA is BILLING CODE 4164–01–P requesting nominations for voting members on TEPRSSC that include DEPARTMENT OF HEALTH AND three general public representatives. DEPARTMENT OF HEALTH AND HUMAN SERVICES I. General Description of the HUMAN SERVICES Committee’s Duties Food and Drug Administration Food and Drug Administration [Docket No. FDA–2018–N–3233] The committee provides advice and consultation to the Commissioner of [Docket Nos. FDA–1999–D–0081, FDA– Request for Nominations for Voting Food and Drugs (Commissioner) on the 2008–D–0205, FDA–2018–D–2173, FDA– Members on a Public Advisory technical feasibility, reasonableness, 2018–D–2236, FDA–2018–D–2238, and FDA– Committee; Technical Electronic and practicability of performance 2018–D–2258] Product Radiation Safety Standards standards for electronic products to Committee control the emission of radiation from Draft Guidances Relating to the such products, and may recommend Development of Human Gene Therapy AGENCY: Food and Drug Administration, electronic product radiation safety Products; Availability; Extension of HHS. standards to the Commissioner for Comment Period ACTION: Notice. consideration. AGENCY: Food and Drug Administration, SUMMARY: The Food and Drug II. Criteria for Voting Members HHS. Administration (FDA) is requesting The committee consists of a core of 15 Notification; extension of ACTION: nominations for members to serve on voting members including the Chair. comment period. the Technical Electronic Product Members and the Chair are selected by Radiation Safety Standards Committee SUMMARY: The Food and Drug the Commissioner or designee from (TEPRSSC) in the Center for Devices Administration (FDA or the Agency) is among authorities knowledgeable in the and Radiological Health. Nominations extending the comment period for the fields of science or engineering, will be accepted for current and notices of availability for six draft applicable to electronic product upcoming vacancies effective with this guidance documents relating to the radiation safety. Members will be notice. development of human gene therapy invited to serve for overlapping terms of FDA seeks to include the views of products that appeared in the Federal up to 4 years. Terms of more than 2 women and men, members of all racial Register of July 12, 2018. The Agency is years are contingent upon the renewal and ethnic groups, and individuals with taking this action in response to of the committee by appropriate action and without disabilities on its advisory requests for an extension to allow prior to its expiration. committees and, therefore, encourages interested persons additional time to nominations of appropriately qualified III. Nomination Procedures submit comments and any new candidates from these groups. information. Any interested person may nominate DATES: Nominations received on or one or more qualified individuals for before November 5, 2018 will be given DATES: FDA is extending the comment membership on the committee. Self- first consideration for membership on period on the six documents that nominations are also accepted. TEPRSSC. Nominations received after published on July 12, 2018 (see Nominations must include a current, November 5, 2018 will be considered for SUPPLEMENTARY INFORMATION). Submit complete résumé or curriculum vitae for nomination to the committee as later either electronic or written comments each nominee, including current vacancies occur. by December 10, 2018, to ensure that the business address and/or home address, ADDRESSES: All nominations for Agency considers your comment on telephone number, and email address if membership should be sent these draft guidances before it begins available, and a signed copy of the electronically by accessing FDA’s work on the final version of the Acknowledgement and Consent form Advisory Committee Membership guidances. available at the FDA Advisory Nomination Portal at https:// Nomination Portal (see ADDRESSES). ADDRESSES: You may submit comments www.accessdata.fda.gov/scripts/ Nominations must also specify the as follows. Please note that late, FACTRSPortal/FACTRS/index.cfm or by advisory committee for which the untimely filed comments will not be mail to Advisory Committee Oversight nominee is recommended. Nominations considered. Electronic comments must and Management Staff, Food and Drug must also acknowledge that the be submitted on or before December 10, Administration, 10903 New Hampshire nominee is aware of the nomination 2018. The https://www.regulations.gov Ave., Bldg. 32, Rm. 5103, Silver Spring, unless self-nominated. FDA will ask electronic filing system will accept MD 20993–0002. Information about potential candidates to provide detailed comments until midnight Eastern Time daltland on DSKBBV9HB2PROD with NOTICES becoming a member on an FDA advisory information concerning such matters at the end of December 10, 2018. committee can also be obtained by related to financial holdings, Comments received by mail/hand visiting FDA’s website at https:// employment, and research grants and/or delivery/courier (for written/paper www.fda.gov/AdvisoryCommittees/ contracts to permit evaluation of submissions) will be considered timely default.htm. possible sources of conflicts of interest. if they are postmarked or the delivery FOR FURTHER INFORMATION CONTACT: This notice is issued under the service acceptance receipt is on or Patricio G. Garcia, Office of Device Federal Advisory Committee Act (5 before that date. VerDate Sep<11>2014 16:56 Sep 05, 2018 Jkt 244001 PO 00000 Frm 00044 Fmt 4703 Sfmt 4703 E:\FR\FM\06SEN1.SGM 06SEN1


Document Created: 2018-09-05 23:56:35
Document Modified: 2018-09-05 23:56:35
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
ActionNotice.
DatesNominations received on or before November 5, 2018 will be given first consideration for membership on TEPRSSC. Nominations received after November 5, 2018 will be considered for nomination to the committee as later vacancies occur.
ContactPatricio G. Garcia, Office of Device Evaluation, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 66, Rm. G610, Silver Spring, MD 20993-0002, 301-796-6875, email: [email protected]
FR Citation83 FR 45249 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR